Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria del Carmen Arango"'
Autor:
Pedro Inocente Mas Bermejo, Maria del Carmen Arango Prado, Rosa Maria Ortiz Reyes, Ania Torres Pombert, Fernando Chuecas, Marcela Cortés‐Jofré, Iraida Caballero Aguirrechu, Rolando Uranga, Cecilia Pacheco
Publikováno v:
Cochrane Database Syst Rev
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of therapeutic vaccines for people with advanced non‐small cell lung cancer (non‐irradiatable stage IIIB and stage IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::122319a1d6223d9ff26d3c48d5979f20
https://europepmc.org/articles/PMC6673723/
https://europepmc.org/articles/PMC6673723/
Autor:
Sonia Franco-Odio, Vicente Madrid-Marina, Reyes Tamez-Guerra, Juan Manuel Alcocer-González, Marta Elena Guerra-Yi, Cristina Rodríguez-Padilla, Leticia Llanes-Fernández, Rolando Camacho-Rodríguez, Maria del Carmen Arango-Prado
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 135:255-264
Breast cancer patients may express abnormal cellular immune responses affecting their immunological competence. The analysis of immunological parameters may be useful as indicators of T cell function. To determine the expression of lymphocyte activat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11093d67f252e90a910fb2c7a2873df9
https://doi.org/10.1007/s00432-008-0446-7
https://doi.org/10.1007/s00432-008-0446-7
Autor:
Reyes Tamez-Guerra, Rolando Camacho-Rodríguez, Rosa Irene Álvarez-Goyanes, Vicente Madrid-Marina, Leticia Llanes-Fernández, Sonia Franco Odio, Maiby Orozco López, Juan Manuel Alcocer-González, Marta Elena Guerra-Yi, Julia Cruz Mojarrieta, Maria del Carmen Arango-Prado, Xiomara Escobar Pérez, Cristina Rodríguez-Padilla
Publikováno v:
The Breast. 15:482-489
Tumor markers are expressed due to molecular alterations of the tumor cells, and we can relate them to the immune system to find new associations to improve prognosis. IL-10 inhibits the generation of immune responses at the tumor site. To determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eca11164a43e3604743003656593b70
https://doi.org/10.1016/j.breast.2005.09.012
https://doi.org/10.1016/j.breast.2005.09.012
Autor:
Marta Osorio, Elías Gracia, Edmundo Rodríguez, Giselle Saurez, Maria del Carmen Arango, Elena Noris, Adriana Torriella, Alejandro Joan, Erasmo Gómez, Lorenzo Anasagasti, Jorge Luis González, María de los Angeles Melgares, Imilla Torres, Joel González, Dayamí Alonso, Enrique Rengifo, Adriana Carr, Rolando Pérez, Luis Enrique Fernández
Publikováno v:
Cancer biologytherapy. 7(4)
NeuGcGM3 ganglioside is especially attractive because it is expressed on melanoma cells but it is minimally or not expressed at all on most normal human tissues. A Phase Ib/IIa clinical trial was carried out in patients with advanced cutaneous and oc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a17d5a474c7ca26ac6074e56e739039d
https://pubmed.ncbi.nlm.nih.gov/18285705
https://pubmed.ncbi.nlm.nih.gov/18285705
Publikováno v:
Revista Cubana de Hematología, Inmunología y Hemoterapia
Los avances recientes en la comprensión de los mecanismos génicos y moleculares del cáncer de mama han revelado que el sistema inmune protagoniza los eventos responsables del desarrollo y la progresión del tumor. Las células de la respuesta inmu
Externí odkaz:
https://doaj.org/article/a91404b972d24c5fbafa69d2533579ad